From around January 2010 to July 2023, Michael Dole, MD, allegedly billed Medicare for more than $32.7 million for routinely testing more than 22 classes of drugs in urine specimens from nearly all his patients at his pain management practice, according to a Sept. 18 news release from the Justice Department.
Dr. Dole tested for these drugs despite a lack of documentation of use or suspicion of use, according to the release. He allegedly received more than $11.7 million in reimbursements and used the proceeds on personal expenses.
Dr. Dole is charged with one count of conspiracy to commit healthcare fraud and five counts of healthcare fraud.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.